Cross Cancer Institute

 

Site:
Cross Cancer Institute
Address:
11560 University Avenue  
City:
Edmonton
State:
AB
Zip:
T6G 1Z2
Country:
Canada

 

6 trials at this site

 

 

3
Terminated
Closed
Nilotinib or Imatinib
NCT00751036
3
Recruiting
Active
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
NCT03673501
3
Ongoing, but not recruiting
Closed
Regorafenib (BAY 73-4506)
NCT01271712
1
Ongoing, but not recruiting
Closed
Regorafenib (BAY 73-4506)
NCT01287598
3
Active, not recruiting
Closed
QINLOCK Ripretinib DCC-2618
NCT03353753
3
Active, not recruiting
Active
Avapritinib or Regorafenib
NCT03465722